NASDAQ | TSX: ACB
- Re-affirms expectation of positive annual Adjusted EBITDA1 for fiscal 2024 and Positive Free Cash Flow1 generation in calendar 2024
- Announces Intention to Consolidate Common Shares
- Q3 2024 Investor Conference call scheduled for February 8, 2024 at 8:00 a.m. Eastern Time
EDMONTON, AB, Jan. 31, 2024 /PRNewswire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, provided key business updates today and confirmed that it will release financial results and host an investor conference call for its third quarter of fiscal 2024 ended December 31, 2023, on February 8, 2024.
Fiscal 2024 Update:
- Adjusted EBITDA1 is expected to be positive on an annual basis in fiscal 2024.
- Management continues to expect that the Company will generate positive free cash flow1 in calendar 2024.
Share Consolidation
Aurora also today…
